/FWPAY
FWPAY Stock - Forward Pharma A/S
Healthcare|BiotechnologyOTC
$300.00-25.09%
$100.50 (-25.09%) • Feb 5
50
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.79
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $330.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for FWPAY
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$297.00 – $303.00
TARGET (TP)$345.00
STOP LOSS$276.00
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.02
52W High$882.86
52W Low$200.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | $1.25B |
| Gross Profit | N/A | N/A | N/A | N/A | $1.23B |
| Gross Margin | N/A | N/A | N/A | N/A | 98.0% |
| Operating Income | $-3,874,000 | $-3,386,000 | $-5,283,000 | $-12,283,000 | $1.19B |
| Net Income | $-1,892,000 | $-6,449,000 | $-4,221,000 | $-8,722,000 | $917.09M |
| Net Margin | N/A | N/A | N/A | N/A | 73.4% |
| EPS | $-77.41 | $-268.72 | $-177.58 | $-368.51 | $9639.99 |
Company Overview
Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
FWPAYBeat Rate
44%
Last 9 quarters
Avg Surprise
+5.3%
EPS vs Estimate
Beats / Misses
4/5
Last 12 quarters
Latest EPS
$-1.75
Q2 2017
EPS Surprise History
Q2 15
No data
Q3 15
-75.0%
$-2.66vs$-1.52
Q4 15
-6.2%
$-2.38vs$-2.24
Q2 16
+45.4%
$-1.43vs$-2.62
Q2 16
-33.3%
$-2.52vs$-1.89
Q3 16
-21.7%
$-2.24vs$-1.84
Q4 16
+34.3%
$-1.61vs$-2.45
Q2 17
+17.5%
$-1.75vs$-2.12
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2017 | Apr 18, 2017 | $-2.12 | $-1.75 | +17.5% | ✓ BEAT |
Q4 2016 | Nov 29, 2016 | $-2.45 | $-1.61 | +34.3% | ✓ BEAT |
Q3 2016 | Sep 1, 2016 | $-1.84 | $-2.24 | -21.7% | ✗ MISS |
Q2 2016 | Jun 2, 2016 | $-1.89 | $-2.52 | -33.3% | ✗ MISS |
Q2 2016 | Apr 12, 2016 | $-2.62 | $-1.43 | +45.4% | ✓ BEAT |
Q4 2015 | Nov 25, 2015 | $-2.24 | $-2.38 | -6.2% | ✗ MISS |
Q3 2015 | Sep 8, 2015 | $-1.52 | $-2.66 | -75.0% | ✗ MISS |
Q2 2015 | Jun 30, 2015 | — | $-757.13 | — | — |
Q2 2015 | May 12, 2015 | $-1.32 | $-1.33 | -0.8% | ✗ MISS |
Q4 2014 | Dec 19, 2014 | $-14.87 | $-1.89 | +87.3% | ✓ BEAT |
Q4 2014 | Oct 14, 2014 | — | $-76.28 | — | — |
Q2 2014 | Jun 30, 2014 | — | $-28.24 | — | — |
Q1 2014 | Mar 31, 2014 | — | $-232.64 | — | — |
Q4 2013 | Dec 31, 2013 | — | $-479.42 | — | — |
Q3 2013 | Sep 30, 2013 | — | $-153.05 | — | — |
Q2 2013 | Jun 30, 2013 | — | $-64.13 | — | — |
Q1 2013 | Mar 31, 2013 | — | $11.39 | — | — |
Latest News
Loading news...
Frequently Asked Questions about FWPAY
What is FWPAY's current stock price?
Forward Pharma A/S (FWPAY) is currently trading at $300.00 per share. The stock has moved -25.09% today.
What is the analyst price target for FWPAY?
No analyst price targets are currently available for this stock.
What sector is Forward Pharma A/S in?
Forward Pharma A/S operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the OTC exchange.
What is FWPAY's market cap?
Forward Pharma A/S has a market capitalization of $0.01 billion, making it a small-cap company.
Does FWPAY pay dividends?
No, Forward Pharma A/S does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBNOEF
Bionomics Limited
$0.01
Mkt Cap: $0.0B
CRBKF
Carebook Technologies Inc.
$0.03
Mkt Cap: $0.0B
FLWPF
The Flowr Corporation
$0.00
Mkt Cap: $0.0B
HBCNF
HealthBeacon plc
$0.50
Mkt Cap: $0.0B
IMUN
Immune Therapeutics, Inc.
$0.09
Mkt Cap: $0.0B
IPCIF
Intellipharmaceutics International Inc.
$0.15
Mkt Cap: $0.0B
POLXF
Polydex Pharmaceuticals Limited
$1.99
Mkt Cap: $0.0B
PSCBF
Pascal Biosciences Inc.
$0.11
Mkt Cap: $0.0B
TBPMF
Tetra Bio-Pharma Inc.
$0.00
Mkt Cap: $0.0B
TRYPF
Tryp Therapeutics Inc.
$0.06
Mkt Cap: $0.0B
Explore stocks similar to FWPAY for comparison